Skip to main content

Clarivate plc (CLVT)

Commercial and Professional Services Industrial Goods
Stock AI

Financial Metrics

Price to Earnings-3.56x
Revenue Growth (1Y)-3.5%
Debt to Equity0.93x

Strengths

Stock Chart

Valuation

Clarivate plc is overvalued

News

All
Press Releases
News
Filings
 Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development
August 06, 2026 Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development
 Clarivate Appoints Michael Easton as Chief Financial Officer
July 29, 2026 Clarivate Appoints Michael Easton as Chief Financial Officer
 Clarivate Reports Second Quarter 2026 Results
July 29, 2026 Clarivate Reports Second Quarter 2026 Results
10-Q Quarterly Report for 2026 Q2
July 29, 202610-Q Quarterly Report for 2026 Q2
 Clarivate RiskMark Wins 2026 CODiE Award for Best AI Tool for Lawyers
July 20, 2026 Clarivate RiskMark Wins 2026 CODiE Award for Best AI Tool for Lawyers
 USPTO Launches AI Image Search in Trademark Search System, Powered by Clarivate
July 16, 2026 USPTO Launches AI Image Search in Trademark Search System, Powered by Clarivate
 Clarivate Selected by Abes to Modernize French National Academic Library System
July 14, 2026 Clarivate Selected by Abes to Modernize French National Academic Library System
 Clarivate to Report Second Quarter 2026 Results on July 29, 2026
July 10, 2026 Clarivate to Report Second Quarter 2026 Results on July 29, 2026
 Clarivate Announces Sale of Life Sciences & Healthcare Segment for $600 Million
July 06, 2026 Clarivate Announces Sale of Life Sciences & Healthcare Segment for $600 Million
 Clarivate Releases 2025 Sustainability Report
June 23, 2026 Clarivate Releases 2025 Sustainability Report
 Clarivate Releases Journal Citation Reports 2026
June 17, 2026 Clarivate Releases Journal Citation Reports 2026
 Clarivate's IPfolio Selected by Mitsubishi Fuso
June 15, 2026 Clarivate's IPfolio Selected by Mitsubishi Fuso
 Clarivate Announces Simon Webster as President of Intellectual Property Segment
June 08, 2026 Clarivate Announces Simon Webster as President of Intellectual Property Segment
 Clarivate Introduces IPOne
May 29, 2026 Clarivate Introduces IPOne
 Clarivate's IPfolio and Renewal Services Selected by IGT
May 21, 2026 Clarivate's IPfolio and Renewal Services Selected by IGT
 Clarivate Selected By Czech National Library of Technology to Develop Unified National Library Platform
May 19, 2026 Clarivate Selected By Czech National Library of Technology to Develop Unified National Library Platform
 Clarivate launches Web of Science Research Intelligence
May 06, 2026 Clarivate launches Web of Science Research Intelligence
 Clarivate Reports First Quarter 2026 Results
April 29, 2026 Clarivate Reports First Quarter 2026 Results
10-Q Quarterly Report for 2026 Q1
April 29, 202610-Q Quarterly Report for 2026 Q1
 Clarivate Introduces Nexus Connect, the First Institutional AI Gateway to Trusted Research and Learning
April 28, 2026 Clarivate Introduces Nexus Connect, the First Institutional AI Gateway to Trusted Research and Learning
 Clarivate to Report First Quarter 2026 Results on April 29, 2026
April 15, 2026 Clarivate to Report First Quarter 2026 Results on April 29, 2026
 Clarivate Reveals the AI50 - the Organizations Leading Artificial Intelligence Invention
March 26, 2026 Clarivate Reveals the AI50 - the Organizations Leading Artificial Intelligence Invention
Consumer Tech News (Mar 9-13): Trump Administration Sues California Over Emissions Targets, Nvidia Announces $26B AI Investment & More
March 15, 2026Consumer Tech News (Mar 9-13): Trump Administration Sues California Over Emissions Targets, Nvidia Announces $26B AI Investment & More
 Clarivate Expands Access to Trusted Regulatory Intelligence Within Claude
March 10, 2026 Clarivate Expands Access to Trusted Regulatory Intelligence Within Claude
 Clarivate to Present at the Wolfe Research FinTech Forum on March 10
March 04, 2026 Clarivate to Present at the Wolfe Research FinTech Forum on March 10
Iran War Escalation, Oil Spike Rattle Wall Street: What's Moving Markets Tuesday?
March 03, 2026Iran War Escalation, Oil Spike Rattle Wall Street: What's Moving Markets Tuesday?
Tech Rebounds On AMD-Meta Deal, Software Stocks Bounce: What's Moving Markets Tuesday?
February 24, 2026Tech Rebounds On AMD-Meta Deal, Software Stocks Bounce: What's Moving Markets Tuesday?
 Clarivate Reports Fourth Quarter and Full Year 2025 Results
February 24, 2026 Clarivate Reports Fourth Quarter and Full Year 2025 Results
10-K Annual Report for 2025 FY
February 24, 202610-K Annual Report for 2025 FY
Stocks Fall, Gold Rallies On Best Day Since 2008: What's Moving Markets Tuesday?
February 03, 2026Stocks Fall, Gold Rallies On Best Day Since 2008: What's Moving Markets Tuesday?
 Clarivate Webinar "Intelligence Amplified in the Age of AI" Highlights How Trusted, Proprietary Data Powers Next‑Generation Innovation
February 03, 2026 Clarivate Webinar "Intelligence Amplified in the Age of AI" Highlights How Trusted, Proprietary Data Powers Next‑Generation Innovation
 Clarivate Announces Full Redemption of Remaining $100 Million Senior Secured Notes Due 2026 and Provides Update on Capital Allocation Activities
February 02, 2026 Clarivate Announces Full Redemption of Remaining $100 Million Senior Secured Notes Due 2026 and Provides Update on Capital Allocation Activities
 Clarivate to Report Fourth Quarter and Full Year 2025 Results on February 24, 2026
January 28, 2026 Clarivate to Report Fourth Quarter and Full Year 2025 Results on February 24, 2026
Top 3 Industrials Stocks You'll Regret Missing This Quarter
January 22, 2026Top 3 Industrials Stocks You'll Regret Missing This Quarter
 Clarivate Introduces Nexus, Connecting AI Users to Trusted Academic Resources
January 22, 2026 Clarivate Introduces Nexus, Connecting AI Users to Trusted Academic Resources
 Clarivate Reveals Top 100 Global Innovators 2026
January 21, 2026 Clarivate Reveals Top 100 Global Innovators 2026
 Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report
January 06, 2026 Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report
S&P 500 Hits All-Time Highs On Christmas Eve, VIX Drops To One-Year Low: What's Moving Markets Wednesday?
December 24, 2025S&P 500 Hits All-Time Highs On Christmas Eve, VIX Drops To One-Year Low: What's Moving Markets Wednesday?
 Nissan Selects IPfolio from Clarivate
December 18, 2025 Nissan Selects IPfolio from Clarivate
10-Q Quarterly Report for 2025 Q3
October 29, 202510-Q Quarterly Report for 2025 Q3
10-Q Quarterly Report for 2025 Q2
July 30, 202510-Q Quarterly Report for 2025 Q2
10-Q Quarterly Report for 2025 Q1
April 29, 202510-Q Quarterly Report for 2025 Q1
10-K Annual Report for 2024 FY
February 19, 202510-K Annual Report for 2024 FY
10-Q Quarterly Report for 2024 Q3
November 06, 202410-Q Quarterly Report for 2024 Q3
10-Q Quarterly Report for 2024 Q2
August 06, 202410-Q Quarterly Report for 2024 Q2
10-Q Quarterly Report for 2024 Q1
May 08, 202410-Q Quarterly Report for 2024 Q1
10-K Annual Report for 2023 FY
February 27, 202410-K Annual Report for 2023 FY
10-Q Quarterly Report for 2023 Q3
November 07, 202310-Q Quarterly Report for 2023 Q3
10-K/A Annual Report for 2022 FY
October 12, 202310-K/A Annual Report for 2022 FY
10-Q Quarterly Report for 2023 Q2
August 07, 202310-Q Quarterly Report for 2023 Q2
10-Q Quarterly Report for 2023 Q1
May 09, 202310-Q Quarterly Report for 2023 Q1
10-K Annual Report for 2022 FY
March 01, 202310-K Annual Report for 2022 FY
10-Q Quarterly Report for 2022 Q3
November 08, 202210-Q Quarterly Report for 2022 Q3
10-Q Quarterly Report for 2022 Q2
August 09, 202210-Q Quarterly Report for 2022 Q2
10-Q Quarterly Report for 2022 Q1
May 09, 202210-Q Quarterly Report for 2022 Q1
10-K Annual Report for 2021 FY
March 10, 202210-K Annual Report for 2021 FY
10-K/A Annual Report for 2020 FY
February 03, 202210-K/A Annual Report for 2020 FY
10-Q/A Quarterly Report for 2021 Q1
February 03, 202210-Q/A Quarterly Report for 2021 Q1
10-Q/A Quarterly Report for 2021 Q2
February 03, 202210-Q/A Quarterly Report for 2021 Q2
10-Q/A Quarterly Report for 2021 Q3
February 03, 202210-Q/A Quarterly Report for 2021 Q3
10-Q Quarterly Report for 2021 Q3
October 28, 202110-Q Quarterly Report for 2021 Q3

A. Company Overview

Clarivate plc is a public limited company established on January 7, 2019, under the jurisdiction of Jersey, Channel Islands. Headquartered at St Paul’s Gate in St. Helier, the company maintains significant operational offices in London, United Kingdom. Clarivate entered public markets in May 2019, with its ordinary shares publicly traded on the New York Stock Exchange under the ticker symbol “CLVT.”

As a prominent global information services provider, Clarivate connects organizations and individuals to trusted intelligence that drives transformation across various sectors. By integrating enriched data, powerful analytics, workflow software, and expert services, the firm services a variety of industries, particularly focusing on Academia & Government (A&G), Intellectual Property (IP), and Life Sciences & Healthcare (LS&H).

B. Business Model

Clarivate's business model emphasizes subscription and technology-driven solutions aimed at providing indispensable and mission-critical services to clients. The organization's strategies focus on accelerating organic growth, enhancing customer experience, and unlocking substantial shareholder value.

To achieve these goals, Clarivate has engaged in strategic acquisitions to bolster product offerings. Notable acquisitions include Decision Resources Group (DRG) and CPA Global in 2020, as well as ProQuest in 2021. These acquisitions augment the company's capabilities across the research and intellectual property (IP) lifecycles, allowing for a comprehensive service delivery model.

The company operates through a diversified revenue stream consisting primarily of:

  • Subscription-Based Revenues: These recurring revenues arise from annual contracts where customers are licensed to use various products or receive maintenance services.
  • Re-occurring Revenues: Particularly relevant to the IP segment, this revenue comes from patent and trademark maintenance services.
  • Transactional Revenues: These revenues are generated through specific deliverables, consulting engagements, and other professional services.

The company's customer base includes numerous prestigious corporations, universities, law firms, and government entities, enabling broad reach and impact across its service segments.

C. Business Segments

Clarivate’s operations are structured into three reportable segments, each fulfilling distinct yet interconnected roles in the marketplace:

Academia & Government (A&G)

The A&G segment accounts for approximately 50% of the company's revenues. Its mission is to enhance research excellence and student success. This segment provides solutions including Research and Analytics, Content Aggregation, and Workflow Software. Clarivate places a strong emphasis on leveraging artificial intelligence (AI) to deliver heightened value. For instance, AI tools are employed to identify and analyze academic journals to maintain high standards of content quality.

Use Cases:

  • Academic researchers utilize tools like the Web of Science to identify emerging research trends and opportunities for collaboration.
  • University administrators assess research performance and resource allocation through comprehensive analytical tools.

Intellectual Property (IP)

Representing around 33% of revenues, the IP segment helps organizations safeguard and manage their intellectual property assets. This includes solutions for IP Maintenance, IP Intelligence, and IP Management. The deployment of AI is particularly notable in its product development, enhancing functionalities such as naming tool automation and trademark searches.

Use Cases:

  • Product designers leverage databases to evaluate the novelty of their innovations.
  • Lawyers conduct thorough trademark clearance searches for new product launches.

Life Sciences & Healthcare (LS&H)

Comprising 17% of revenues, the LS&H segment supports organizations seeking to improve patient outcomes through effective drug development and commercialization strategies. The intelligence solutions provided in this sector offer insights for drug discovery and development, regulatory compliance, and market analysis.

Use Cases:

  • Pharmaceutical researchers benchmark their development programs against competitive products using integrated databases.
  • Medical technology analysts target specific patient demographics for commercialization strategies.

D. Customer Relationships

Clarivate's customer base spans a vast global landscape, serving clients across more than 150 countries. Notably, the company services nearly all of the top 400 universities and over 95% of the top 50 research and development companies, ensuring a broad and diverse clientele.

The firm has recognized the growing importance of data in the decision-making processes of its customers. By curating vast amounts of unstructured data into meaningful information through rigorous aggregation, verification, and standardization practices, Clarivate solidifies its reputation as a provider of trusted solutions.

The business emphasizes high customer retention rates, often exceeding 90%, which reflects the overall satisfaction and reliability of its services among clients.

E. Competitive Landscape

Clarivate operates in a competitive landscape where key success factors include the quality and accuracy of data, ease of access to content, and overall value proposition. While there are competitors within specific niches, Clarivate's unique combination of extensive offerings and advanced technological integration sets it apart.

The company is committed to protecting its intellectual property through a robust approach that combines statutory protections and strategic partnerships, maintaining its competitive edge in the marketplace.

Stock Infos

SectorIndustrial Goods
IndustryCommercial and Professional Services
CEOMatti Shem Tov

Dividends

Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.